UTEP professor's study may lead to solutions for overeating

February 12, 2021

EL PASO, Texas - Science is a step closer to a new response to obesity, thanks in part to a study conducted by a team that included Sergio Iñiguez, Ph.D., associate professor of psychology at The University of Texas at El Paso.

The 10-member team led by Brandon Warren, Ph.D., assistant professor of pharmacodynamics at the University of Florida, made discoveries about a specific area of the brain tied to recollection and the desire to seek and consume food. It could lead to a way to inhibit the desire to overeat.

Iñiguez, who directs UTEP's Iñiguez Behavioral Neuroscience Lab and helped design novel experimental techniques for the research, said that people tend to overeat when exposed to cues or environments that remind them of treats, which is one reason why people opt for dessert even after a filling meal. The study showed that neurons in a specific part of the brain control the link between the cue (seeing the dessert) and the action (ordering the dessert). Iñiguez and team found that animal subjects consumed fewer treats when they regulated that region of the animal's brain.

The techniques and the data eventually could help overcome some issues linked to obesity such as stroke, Type 2 diabetes, high blood pressure, high levels of bad cholesterol, and coronary heart disease.

"This is a big discovery because we now have experimental tools that allow us to turn off neurons while the subjects engage in a specific behavior," Iñiguez said. "This research shows that a specific part of the prefrontal cortex of the brain is important for the initial stages of learning to seek food."
-end-
Research results were published recently in eNeuro, a journal of the Society for Neuroscience.

The latest journal publication comes on the heels of a successful 2020 for Iñiguez, when his research was published in three top journals: Neuropsychopharmacology, Biological Psychiatry and Proceedings of the National Academy of Sciences of the United States of America.

The University of Texas at El Paso is one of the largest and most successful Hispanic-serving institutions in the country, with a student body that is 83% Hispanic. It enrolls nearly 25,000 students in 166 bachelor's, master's and doctoral programs in 10 colleges and schools. With more than $100 million in total annual research expenditures, UTEP is ranked in the top 5% of research institutions nationally and fifth in Texas for federal research expenditures at public universities.

University of Texas at El Paso

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.